VKTX

Viking Therapeutics is a biotech company developing drugs to treat metabolic and hormonal disorders like fatty liver disease, muscle loss after hip fractures, and anemia. The company's main experimental drug, VK2809, is designed to treat a condition where fat builds up in the liver. Viking's other drug candidates are still in early-stage testing and not yet approved for patients. The company was founded in 2012 and is based in San Diego.